Therapy of renal cell carcinoma. 3. Interferon therapy

Therapy of renal cell carcinoma. 3. Interferon therapy

Human lymphoblastoid interferon (HLBI-alpha) or recombinant human leukocyte interferon (HLIF-alpha) was administered to ten patients suffering from renal cell carcinoma at a daily dose of 5 X 10(6) units. The efficacy of interferon was assessed in nine patients who had received HLBI-alpha or HLIF-al...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 33(1987), 4 vom: 01. Apr., Seite 508-14
1. Verfasser: Kobayashi, M (VerfasserIn)
Weitere Verfasser: Imai, K, Kiren, H, Nakai, K, Saruki, K, Umeyama, T, Ito, Y, Yamanaka, H, Makino, T, Machida, M
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1987
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports English Abstract Journal Article Interferon Type I Recombinant Proteins